These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3248105)

  • 1. Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action.
    Thiemermann C; Ney P; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S19-22. PubMed ID: 3248105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.
    Thiemermann C; Thomas GR; Vane JR
    Br J Pharmacol; 1989 Jun; 97(2):401-8. PubMed ID: 2758223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
    Schrör K; Thiemermann C; Ney P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
    Johnson G; Tsao PS; Mulloy D; Lefer AM
    J Pharmacol Exp Ther; 1990 Jan; 252(1):35-41. PubMed ID: 2153807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of free radicals in the cardioprotective effect of defibrotide.
    Haklar G; Erşahin C; Moini H; Süngün M; Doğan N; Bilsel S; Emerk K; Yalçin AS
    Arzneimittelforschung; 1996 Apr; 46(4):381-4. PubMed ID: 8740083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
    Xu D; Zhang S; Foster DJ; Wang J
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of rat heart from damage due to ischemia-reperfusion during procurement and grafting by defibrotide.
    Ferrero ME; Marni A; Parise M; Salari PC; Gaja G
    Transplantation; 1991 Oct; 52(4):611-5. PubMed ID: 1926339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.
    Murohara T; Margiotta J; Phillips LM; Paulson JC; DeFrees S; Zalipsky S; Guo LS; Lefer AM
    Cardiovasc Res; 1995 Dec; 30(6):965-74. PubMed ID: 8746213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved metabolic function of rat heart during procurement using defibrotide.
    Ferrero ME; Marni A; Aimini R; Bergamasco E; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2230-2. PubMed ID: 2171166
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioprotective effects of defibrotide: a minireview.
    Pescador R; Porta R; Mantovani M; Prino G
    Semin Thromb Hemost; 1991; 17 Suppl 1():96-100. PubMed ID: 2068573
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
    Ma XL; Weyrich AS; Krantz S; Lefer AM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1229-36. PubMed ID: 1545390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
    Ma XL; Porta R; Pescador R; Lefer AM
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):667-74. PubMed ID: 1663194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart.
    Shin YK; Campbell B; Lefer AM
    Methods Find Exp Clin Pharmacol; 1998; 20(6):463-71. PubMed ID: 9789870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system.
    Berti F; Rossini G; Omini C; Daffonchio L; Tondo C; Cali G
    Pol J Pharmacol Pharm; 1987; 39(5):657-65. PubMed ID: 3506734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
    Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
    Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning".
    Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):108-15. PubMed ID: 1708043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.